Raquel Ortiz
Bellaterra, CT 08193, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
VLPs generated by the fusion of RSV-F or hMPV-F glycoprotein to HIV-Gag show improved immunogenicity and neutralizing response in mice.
Journal: Vaccine
Published: January 09, 2024
Virus-like particle-mediated delivery of structure-selected neoantigens demonstrates immunogenicity and antitumoral activity in mice.
Journal: Journal of translational medicine
Published: October 23, 2023
Novel Spike-stabilized trimers with improved production protect K18-hACE2 mice and golden Syrian hamsters from the highly pathogenic SARS-CoV-2 Beta variant.
Journal: Frontiers in immunology
Published: September 10, 2023
Immunization with V987H-stabilized Spike glycoprotein protects K18-hACE2 mice and golden Syrian hamsters upon SARS-CoV-2 infection.
Journal: Nature communications
Published: April 21, 2023
Exploring FeLV-Gag-Based VLPs as a New Vaccine Platform-Analysis of Production and Immunogenicity.
Journal: International journal of molecular sciences
Published: April 14, 2023
Alanine-based spacers promote an efficient antigen processing and presentation in neoantigen polypeptide vaccines.
Journal: Cancer immunology, immunotherapy : CII
Published: October 17, 2022
An engineered HIV-1 Gag-based VLP displaying high antigen density induces strong antibody-dependent functional immune responses.
Journal: NPJ vaccines
Published: May 06, 2022
The Characteristics of the HIV-1 Env Glycoprotein Are Linked With Viral Pathogenesis.
Journal: Frontiers in microbiology
Published: August 23, 2021
Clinical course impacts early kinetics,magnitude, and amplitude of SARS-CoV-2 neutralizing antibodies beyond 1 year after infection.
Journal: Cell reports. Medicine
Published: August 23, 2021
Last Updated: 09/26/2026